As well being programs race to deploy generative AI options for medical documentation, startups within the house are jockeying for place. A kind of distributors, Pittsburgh-based Abridge, has simply picked up a further $150 million funding and a big new buyer in Yale New Haven Well being System.
The brand new funding comes simply 4 months after Abridge raised $30 million in a Sequence B funding spherical.
Abridge mentioned the cope with the Yale New Haven Well being System, the most important and most complete healthcare system in Connecticut, will give hundreds of clinicians entry to Abridge for medical documentation. Yale New Haven Well being has chosen Abridge as their generative AI companion on this space of ambient listening. The preliminary deployment shall be targeted on decreasing the cognitive burden of medical documentation, enabling clinicians to spend extra face-to-face time participating with sufferers as an alternative of computer systems.
In August 2023, Healthcare Innovation interviewed Alistair Erskine, M.D., M.B.A., chief info and digital officer of Atlanta-based Emory Healthcare, about why his group signed an enterprise-wide settlement to make Abridge’s Epic-integrated answer for note-taking accessible to Emory clinicians over the subsequent three years.
“What I used to be shocked about with Abridge, and what sort of piqued my curiosity, is that its expertise is throughout the board. I need not wait till it tells me ‘Okay, we’re good for cardiologists now.’ Proper now, I’ve 20 docs utilizing it, and it is throughout all completely different specialties and I am getting the identical constructive suggestions from all of them,” Erksine mentioned. (Since that interview, Emory’s Abridge consumer base has grown to greater than 500 docs.)
Abridge mentioned its “Linked Proof” characteristic maps any highlighted area inside a abstract to the substantiating proof within the supply transcript (and thus to the underlying audio). The corporate additionally mentioned it’s growing novel methods to personalize notes, combine extra deeply into the EHR, and supply clinicians with after-visit insights.
The Sequence C funding was led by Lightspeed Enterprise Companions, who can even be a part of the board. Different new and current buyers embody co-lead Redpoint Ventures, with assist from IVP, Spark Capital, Union Sq. Ventures, Bessemer Enterprise Companions, Wittington Ventures, Mass Normal Brigham Synthetic Intelligence and Digital Innovation Fund (AIDIF), Kaiser Permanente Ventures, and CVS Well being Ventures.
